PETQ Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 109308 min ago

@ $17.87

Ausgestellt: 13 Feb 2024 @ 21:58

Rendite: -8.23%

Vorheriges Signal: Feb 13 - 15:30

Vorheriges Signal: Kaufen

Rendite: -1.05 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:45):

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services...

Stats
Tagesvolumen	86 575.00
Durchschnittsvolumen	304 245
Marktkapitalisierung	483.52M
EPS	$0 ( 2024-02-28 )
Nächstes Ertragsdatum	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	234.29
ATR14	$0.0190 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Christensen Mccord	Buy	5 680	Class A Common Stock
2024-03-12	Christensen Mccord	Sell	2 236	Class A Common Stock
2024-03-12	Christensen Mccord	Sell	5 680	Restricted Stock Unit
2024-03-12	Smith Michael A	Buy	1 581	Class A Common Stock
2024-03-12	Smith Michael A	Sell	714	Class A Common Stock

INSIDER POWER
49.82
Last 99 transactions
Buy: 1 116 608 \| Sell: 323 106

Volumen Korrelation

Lang: 0.10 (neutral)

Kurz: -0.67 (moderate negative)

Signal:(36.995) Neutral

PetIQ Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

PetIQ Inc Korrelation - Währung/Rohstoff

0.26
( neutral )

0.17
( neutral )

0.00
( neutral )

0.87
( strong )

-0.34
( neutral )

PetIQ Inc Finanzdaten

Annual	2023
Umsatz:	$1.10B
Bruttogewinn:	$252.74M (22.94 %)
EPS:	$0.0731

FY	2023
Umsatz:	$1.10B
Bruttogewinn:	$252.74M (22.94 %)
EPS:	$0.0731

FY	2022
Umsatz:	$921.51M
Bruttogewinn:	$209.66M (22.75 %)
EPS:	$-1.670

FY	2021
Umsatz:	$932.53M
Bruttogewinn:	$186.39M (19.99 %)
EPS:	$-0.570

Financial Reports:

No articles found.

PetIQ Inc

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.